| Document |
Document Title |
|
WO/2020/068235A1 |
A method of treating cellulosic materials with a barrier coating comprising at least two polyol and/or saccharide fatty acid ester, having different HBL values, that provides increased water, oil and grease resistance to such materials w...
|
|
WO/2020/068582A1 |
An alkyd polymer composition for fast-drying, low VOC applications is provided. The alkyd polymer incorporates a minimum required level of a cyclic ether- and hydroxyl-containing composition formed from a sugar alcohol during the alcohol...
|
|
WO/2020/064788A1 |
The present disclosure relates generally to terpene glycosides, such as certain such compounds extracted from Stevia rebaudiana Bertoni, Rubus suavissimus, or Siraitia grosvenorii. The disclosure also provides for the use of such compoun...
|
|
WO/2020/058889A1 |
The present patent application relates to the use of an innovative amino acid derivative of glucosamine having the Formula 1 of the general structure which follows, or of a pharmaceutical composition which contains it as a single active ...
|
|
WO/2020/056124A1 |
The present invention describes tunable methods of treating cellulosic materials with a barrier coating comprising a prolamine and at least one polyol fatty acid ester that provides increased oil and/or grease resistance to such material...
|
|
WO/2020/032272A1 |
The present invention provides a production method for sugar fatty acid esters. The production method is characterized in that a weakly basic ion exchanger that has a pKb of 3–7 is used as a catalyst to react a fatty acid ester and a s...
|
|
WO/2020/025693A1 |
Compositions containing monoester derivatives of the primary alcohol residue of a sugar are generally disclosed herein, as well as their use as sweetness enhancers, bitterness maskers, sourness maskers, or astringency reducers, to improv...
|
|
WO/2020/027882A1 |
Disclosed herein is a method of producing high purity pentagalloyl glucose (PGG), analogues or derivatives thereof, at least 99.9% pure, by washing with dimethyl ether. PGG may be provided in a kit, including a hydrolyzer for dissolving ...
|
|
WO/2020/015612A1 |
A fucosylated chondroitin sulfate oligosaccharide having the structure as shown in J, and further disclosed is a method for preparing the fucosylated chondroitin sulfate oligosaccharide: using a chondroitin sulfate A salt as a raw materi...
|
|
WO/2020/014669A1 |
Thrombin-inhibiting acylated pyrazole-pyridone compounds of formula (II) are disclosed herein, as well as pharmaceutical compositions, including tablets, that contain acylated pyrazole- pyridone compounds. These compounds are useful for ...
|
|
WO/2019/230978A1 |
The present invention provides a tannic acid based surface-active compounds, a method of producing tannic acid based surface-active compounds and a dispersing composition including the Tannic acid based surface-active compounds. Consider...
|
|
WO/2019/228408A1 |
Provided herein are potent compounds of Formula (I) and uses thereof for inhibiting the activity of D-amino acid oxidase (DAAO) or treating diseases or disorders associated with DAAO, such as a central nervous system (CNS) disorder, pain...
|
|
WO/2019/227525A1 |
An application of a chitooligosaccharide-based compound as a biomaterial, especially as a fluorescent molecule carrier. The chitooligosaccharide-based compound has a structure represented by formula (I) with chitooligosaccharide having d...
|
|
WO/2019/230979A1 |
The present invention provides a method of dispersing asphaltene contained in crude oil and method of dispersing asphaltene contained in asphalt cement. Considering the importance of renewable surfactants for long-term sustainable develo...
|
|
WO/2019/227228A1 |
The present disclosure relates to analogs of N-acetyl glucosamine fluorinated at 4- and/or 6-position(s) and derivatives of xylose at anomeric position for the treatment of a neurological disease, inflammation, cancer and a central nervo...
|
|
WO/2019/230980A1 |
The present invention provides a method of dispersing crude oil emulsion containing a tannic acid based surface-active compounds. Considering the importance of renewable surfactants for long-term sustainable development we have developed...
|
|
WO/2019/223485A1 |
A method for synthesizing sucrose-6-ester. The method comprises: (a) in the presence of a polar aprotic solvent, contacting an organic phosphine compound represented by formula I with sucrose and an organic tin compound; (b) removing wat...
|
|
WO/2019/222424A1 |
Disclosed are cationic lipids which are compounds of Formula (I'). Cationic lipids provided herein can be useful for delivery and expression of mRNA and encoded protein, e.g., as a component of liposomal delivery vehicle, and accordingly...
|
|
WO/2019/197595A2 |
The invention relates to novel compounds (I), the use of compounds in eliciting a pro-Th17 immune response and related aspects. Further provided are methods of production of said compounds (I).
|
|
WO/2019/196697A1 |
A small molecule mannose analog for the manufacture of a recombinant antibody having complex N-linked glycans but reduced core fucosylation. Said mannose analog is typically taken in by host cells (e.g. by means of active transport or pa...
|
|
WO/2019/193214A1 |
The invention relates to a method for obtaining a mixture of sucrose monotartrate and sucrose ditartrate and to the use of same to inhibit precipitations in wine by dissolving same in the wine after a process of fermentation, clarificati...
|
|
WO/2019/193556A1 |
The invention relates to a method for extracting oligofucanes from brown algae, to the compositions resulting from said extraction, and to the applications thereof. Said method comprises the following successive steps: (a) depolymerisati...
|
|
WO/2019/179325A1 |
The present invention relates to the field of carbohydrate chemistry, and discloses a preparation method for a surface capsular polysaccharide structural derivative of Gram-positive bacteria. In the present invention, glucose is used as ...
|
|
WO/2019/169496A1 |
Provided herein are methods of treating constipation in subjects in need thereof. The method includes administering a therapeutically effective dosage of N-acetylglucosamine. Subjects who may benefit from treatment include those having s...
|
|
WO/2019/154195A1 |
The present invention relates to a novel therapeutic drug for a neurodegenerative disease and an application thereof. Provided is a novel compound of formula (I). The compound can effectively facilitate the proliferation of neural stem c...
|
|
WO/2019/154306A1 |
Disclosed in the present invention are saccharide derivatives for immune cell surface modification and use thereof. The saccharide derivatives of the present invention are 9-position or 5-position target substituent modified 9-carbon mon...
|
|
WO/2019/151128A1 |
A cell labeling agent according to the present invention includes a monosaccharide derivative having a six-membered ring structure metabolized by sialic acid in a sialic acid biosynthesis pathway of a cell. Among groups bonded to carbon ...
|
|
WO/2019/145562A1 |
The present invention relates to anew class of sialyltransferase inhibitors. The class features a carbamate or similar moiety on the amine of a neuraminic acid derivative. Such inhibitors are suitable for use as a medicament, for example...
|
|
WO/2019/128410A1 |
The present invention relates to the preparation of various xylan esterification products, and an application thereof in a drug for preventing, alleviating and/or treating inflammatory diseases. The application of a xylan esterification ...
|
|
WO/2019/119117A1 |
There are provided compounds of Formula (A) and pharmaceutically acceptable salts and esters thereof, and pharmaceutical compositions thereof, used for the prevention or treatment in a mammal of joint and bone disorders such as arthritis...
|
|
WO/2019/109300A1 |
Improved enrichment methods for preparing tannic acid compositions that have superior potency in inhibiting D-amino acid oxidase, and superior purity and safety profiles. The tannic acid compositions (e.g., pharmaceutical compositions, n...
|
|
WO/2019/101489A1 |
The present invention describes an efficient way to isolate a sialic acid from a fermentation broth. The sialic acid contained in the fermentation broth is produced by bacterial fermentation. The inventive process comprises a step of rem...
|
|
WO/2019/092572A1 |
The present invention relates to new synthetic molecules with agonist activity of human Toll-like Receptor 4 (TLR4), compositions comprising them and uses thereof for the treatment of diseases in which it is useful to induce or increase ...
|
|
WO/2019/088855A1 |
The invention relates to branched trehalose glycolipids of Formula (I) and their uses. These compounds are potent Mincle agonists and Th1-stimulating vaccine adjuvants.
|
|
WO/2019/088854A1 |
The invention relates to brartemicin analogues of Formula (IV) and their uses. These compounds are potent Mincle agonists and Th1-stimulating vaccine adjuvants.
|
|
WO/2019/063955A1 |
The present invention concerns the compounds of the following formula (I): (I) in which: - X represents an oxygen atom, a sulfur atom, a nitrogen atom or a CH radical, - The X--Y bond and Y are absent if X represents an oxygen or sulfur ...
|
|
WO/2019/053700A2 |
Probe embodiments for identifying analytes involved in biofuel or bioenergy production, bioremediation, or nutrient cycling as well as methods of making and use are described herein. In some embodiments, probes identifying cellulose degr...
|
|
WO/2019/049044A1 |
A glycoside compound of fatty acids that comprises the general formula: GalNAc-GalNAc-Glc-O-R, where GalNAc is a- or β-D-N-acetylgalactosamine, Glc-O-R is a molecule of a- or β-D-glucose esterified to a monounsaturated fatty acid (R), ...
|
|
WO/2019/002594A1 |
The present invention discloses a method for separating chromatographically indistinguishable 1,2-diaxial from 1,2- diequatorial disaccharide 2-azido-1-nitrates, wherein the disaccharide is a 1→4 disaccharide, comprising the steps of -...
|
|
WO/2018/221562A1 |
According to the present invention, it is found that dopamine D2-like receptor agonists acts on a dopamine D2-like receptor in an activated Th cell and thereby inhibits the production of Interleukin-8 (IL-8).
|
|
WO/2018/205009A1 |
Processes for the preparation of phosphorylated heptose compounds are provided. Embodiments of the invention relate to the chemical synthesis of heptopyranose phosphate compounds. Also, embodiments of the invention relate to the use of c...
|
|
WO/2018/204302A1 |
The present disclosure relates to phosphorylated hexaacyl disaccharide (PHAD) compounds, compositions, and methods for treating or preventing infections.
|
|
WO/2018/181872A1 |
This resist composition contains at least one type of tannin compound selected from the group consisting of a tannin containing at least one crosslinkable reactive group in the structure, a derivative of said tannin, and a resin obtained...
|
|
WO/2018/166159A1 |
Disclosed are a Pezicula sp. SC1337 strain and a method for preparing trisaccharide ester derivatives using same. The preservation number of Pezicula sp. SC1337 is GDMCC No: 60144. Pezicula sp. SC1337 can be obtained by means of separati...
|
|
WO/2018/166158A1 |
Disclosed are a fungal trisaccharide ester compound and an application thereof in preparation of medicines for preventing and controlling plant fungus diseases. (Pezicula sp.) SC1337 can be separated from endophytes in branches of Taxodi...
|
|
WO/2018/170420A1 |
Provided herein are compositions comprising lipotechoic acid (LTA) and methods of use thereof for immune modulation. In particular, compositions comprising S. epidermidis lipotechoic Acid (SELTA) are provided, as well as method of use th...
|
|
WO/2018/155051A1 |
Provided is lipid A, which has a novel structure. More specifically, provided is lipid A which can be used in an adjuvant, and with which side effects such as allergic reaction and inflammation are reduced, while maintaining an excellent...
|
|
WO/2018/149359A1 |
The present invention provides a triazole antibacterial derivative and a pharmaceutical composition and a use thereof, and in particular relates to a compound represented by the following formula (I), and a racemate, a stereoisomer, a ta...
|
|
WO/2018/129603A1 |
Process for producing a rhamnolipid produced by Pseudomonas or Enterobacter using andiroba or murumuru seed waste, pertaining to the sector of compounds containing monosaccharide radicals, consists of producing rhamnolipids by a biotechn...
|
|
WO/2018/086330A1 |
The present invention discloses a method for preparing sucralose-6-acylate in a biphasic liquid-liquid system. The method comprises slowly dropwise adding an inert non-polar solvent containing a chlorinating agent to an N,N-dimethyl form...
|
